It is a fmcg private limited company based in Pune, Maharashtra, India, established in 2018.
2018 | Pune, Maharashtra, India | ActiveDrtherapeutics International Pharmaceuticals Private Limited, a active private limited company, was established on 28 February 2018 in Pune, Maharashtra, India. Engaging in personal care & skincare products within the trade sector, it holds CIN: U74999PN2018PTC175028. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Kamal Puri Durwas (Director), Leena Nilesh Puri (Director). Past directors included Kamal Puri Durwas, Sudesh Durvas Puri. It holds ₹2.10 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Atria, B-2/109, Sr No-29/1 Nr-R K Puram, Munjabawas, Dhanori, Pune, Maharashtra, 411015.
U74999PN2018PTC175028
175028
28 February 2018
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Drtherapeutics International Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Puri Durwas | Director | 21 Feb 2019 | Current |
| Leena Nilesh Puri | Director | 28 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2019 | Past |
| Pramod Abcsdd | Director | 21 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Drtherapeutics International Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.78% decrease. The company also saw a substantial fall in profitability, with a 91.72% decrease in profit. The company's net worth moved up by a moderate rise of 1.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Drtherapeutics International Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,100,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2020 | Idbi Bank Limited | ₹2.10 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Drtherapeutics International Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Drtherapeutics International Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drtherapeutics International Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Drtherapeutics International Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Drtherapeutics International Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
A charge with Idbi Bank Limited amounted to Rs. 2.10 M with Charge ID 100393607 was registered on 22 Sep 2020. was recorded as a recent event.
Kamal Puri Durwas was appointed as a Director was appointed as a Director on 21 Feb 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Leena Nilesh Puri was appointed as a Director was appointed as a Director on 28 Feb 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
Progress on Drtherapeutics International Pharmaceuticals Private Limited was registered on 28 Feb 2018 with Roc Pune & aged 7 years 9 months as per MCA records. was documented.
The CIN of Drtherapeutics International Pharmaceuticals Private Limited is U74999PN2018PTC175028.
Drtherapeutics International Pharmaceuticals Private Limited is headquartered at Atria, B-2/109, Sr No-29/1 Nr-R K Puram, Munjabawas, Dhanori, Pune, Maharashtra, 411015.
Drtherapeutics International Pharmaceuticals Private Limited was incorporated on 28 February 2018.
The current directors of Drtherapeutics International Pharmaceuticals Private Limited are
The primary industry of Drtherapeutics International Pharmaceuticals Private Limited is Trade.
Drtherapeutics International Pharmaceuticals Private Limited is unlisted.
The authorized capital of Drtherapeutics International Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX